The clinical burden of allergic rhinitis in five Middle Eastern countries: results of the SNAPSHOT program.
Ahmed Al-Digheari, Bassam Mahboub, Hesham Tarraf...
https://pubmed.ncbi.nlm.nih.gov/30473712/Actively Recruiting
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2024-12-09
40
Participants Needed
1
Research Sites
156 weeks
Total Duration
Researchers are studying the effects of ZhenQi FuZheng granules on allergic rhinitis, a condition involving nasal inflammation. This research combines clinical studies with laboratory experiments on cells and animals to better understand how the treatment may influence intestinal flora and metabolites. The goal is to see if this treatment can improve immune balance and reduce type 2 inflammation in patients with allergic rhinitis. Participants in this study will take ZhenQi FuZheng granules orally, one bag twice a day, for 4 weeks. The study involves collecting biological samples and questionnaires to analyze changes in nasal inflammatory factors and nasal secretions. The research is sponsored by The First Affiliated Hospital with Nanjing Medical University and focuses on linking clinical outcomes with basic scientific research. During the 12 weeks of follow-up, researchers will assess participants using the Rhinoconjunctivitis Quality of Life Questionnaire and a Visual Analog Score for pain to monitor improvements related to allergic rhinitis symptoms. Participants will be monitored for any changes and effects of the treatment during this period, ensuring detailed collection of data on quality of life and pain levels.
CONDITIONS
Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites
L
Lei Cheng
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants take ZhenQi FuZheng granules orally twice a day for 4 weeks.
1 baseline visit and weekly visits during treatment
Duration - Up to 12 weeks
Participants are monitored for outcomes including quality of life and pain for up to 12 weeks after starting treatment.
Periodic follow-up visits up to 12 weeks
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Ahmed Al-Digheari, Bassam Mahboub, Hesham Tarraf...
https://pubmed.ncbi.nlm.nih.gov/30473712/Lei Cheng, Jianjun Chen, Qingling Fu...
https://pubmed.ncbi.nlm.nih.gov/29949830/Keqiong Li, Yi Chen, Rong Jiang...
https://pubmed.ncbi.nlm.nih.gov/28586019/X D Wang, M Zheng, H F Lou...
https://pubmed.ncbi.nlm.nih.gov/26948849/A O Eifan, S R Durham
https://pubmed.ncbi.nlm.nih.gov/27434218/The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor